✦ LIBER ✦

Quality of survival in histiocytosis X: A southwest oncology group study

✍ Scribed by Komp, Diane M. ;Mahdi, Anas El ;Starling, Kenneth A. ;Easley, James ;Vietti, Teresa J. ;Berry, D. H. ;George, Stephen L.

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 303 KB
Volume: 8
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950080106

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Sixty children survived for five years after the diagnosis of histiocytosis X. Serious disabilities were seen in 50% of children whose disease involved soft tissue and bone. Late deaths from pulmonary failure were associated with opportunistic infections in two cases.

Future treatment approaches must weigh the risks of therapy‐related complications against the probability of significant disability if the disease continues for many years.

📜 SIMILAR VOLUMES

A staging system for histiocytosis X: A

A staging system for histiocytosis X: A southwest oncology group study

✍ Diane M. Komp; Jay Herson; Kenneth A. Starling; Teresa J. Vietti; Eva Hvizdala 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

Natural history of histiocytosis X: A pe

Natural history of histiocytosis X: A pediatric oncology group study

✍ Berry, D. H. ;Gresik, Mary V. ;Humphrey, G. Bennett ;Starling, Kenneth ;Vietti, 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

The best therapy for patients with histiocytosis X with disease involvement other than isolated bone lesions but without organ dysfunction is unclear. This retrospective study was undertaken to define the natural history of this group of patients. In 25 of the 92 studied patients, there was no prog

Bisantrene hydrochloride in gastric aden

Bisantrene hydrochloride in gastric adenocarcinoma: A southwest oncology group study

✍ Panettiere, Frank J. ;Jones, Stephen E. ;Oishi, Noboru ;Eyre, Harmon J. ;O'Bryan 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Because "the standard" chemotherapy for advanced gastric adenocarcinoma, the FAM combination of 5-fluorouracil, adriamycin, and mitomycin, is only minimally effective, there is a clear need for other choices. Therefore, the Southwest Oncology Group tested the new adriamycin analog, bisantrene, hopin

Adjuvant chemotherapy in nonmetastatic o

Adjuvant chemotherapy in nonmetastatic osteosarcoma: A southwest oncology group study

✍ Herson, Jay ;Sutow, Wataru W. ;Elder, Karin ;Vietti, Teresa J. ;Falletta, John M 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

## Abstract This report updates experience with the CONPADRI‐I, COMPADRI‐II, and COMPADRI‐III adjuvant chemotherapy programs for the treatment of nonmetastatic osteosarcoma. A total of 200 patients received one of the three regimens. The analysis of response to treatment is based on disease‐free su

Phase II evaluation of bleomycin. A Sout

Phase II evaluation of bleomycin. A Southwest Oncology Group study

✍ Charles D. Haas; Charles A. Coltman Jr.; Jeffrey A. Gottlieb; Arthur Haut; James 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 2 views

Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and

Management of adult acute leukemia a sou

Management of adult acute leukemia a southwest oncology group study

✍ Kenneth B. McCredie; Edmund A. Gehan; Emil J. Freireich; James S. Hewlett; Charl 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB